Intron Labs: Pioneering Immunotherapy for the Brain

🧠Intron Labs is harnessing the neuroimmune axis to develop innovative treatments for inflammatory and neurological disorders.

🧬Their scientific co-founders, Dr. June Ha from Harvard Medical School and Dr. Gloria Choi from MIT, published a groundbreaking discovery in Nature that certain immune molecules can modulate neural activity.

🔬Their research focuses on the development of immunotherapies for conditions like autism.

💡Intron Labs believes that by targeting the neuroimmune axis, they can provide innovative solutions for the treatment of brain-related disorders.

🎯Their goal is to develop novel therapeutics that can effectively modulate neural activity and improve the lives of individuals with inflammatory and neurological disorders.

What is Intron Labs working on?

—Intron Labs is working on developing immunotherapy for the brain, focusing on inflammatory and neurological disorders, starting with autism.

Who are the scientific co-founders of Intron Labs?

—The scientific co-founders of Intron Labs are Dr. June Ha from Harvard Medical School and Dr. Gloria Choi from MIT.

What was their groundbreaking discovery?

—They discovered that certain immune molecules can modulate neural activity, and this forms the basis of their research at Intron Labs.

What is the neuroimmune axis?

—The neuroimmune axis refers to the interaction between the immune system and the nervous system. Intron Labs is harnessing this axis to develop innovative treatments for brain-related disorders.

What is the goal of Intron Labs?

—The goal of Intron Labs is to develop novel therapeutics that can effectively modulate neural activity and improve the lives of individuals with inflammatory and neurological disorders.

00:00Paul Singh is the CEO of Intron Labs, a company pioneering immunotherapy for the brain.

00:08Dr. June Ha from Harvard Medical School and Dr. Gloria Choi from MIT made a significant discovery that certain immune molecules can modulate neural activity.

00:23Intron Labs is using the neuroimmune axis to develop innovative therapeutics for inflammatory and neurological disorders, starting with autism.

00:31Intron Labs is grateful for the opportunity to present their work and express their appreciation for the support received.